Letter | Published:

Mechanism of activation of HuBlym-1 gene unresolved

Naturevolume 321pages437438 (1986) | Download Citation



The HuBlym-1 gene has been isolated from Burkitt's lymphoma DNA on the basis of its reported ability to produce foci of cells when NIH 3T3 cells are transfected with it1,2. The sequence of HuBlym-1 has been reported1 but it has not been established whether the sequence of the transforming gene differs from that of the gene in normal tissue, as might be expected from the common observation of mutational activation of proto-oncogenes into oncogenes. I report here that there are no differences between the sequences of three recombinant DNA clones that were isolated from Burkitt's cell lines and that cross-hybridize to HuBlym-1 but do not induce foci when transfected into NIH 3T3 cells, and the reported sequence of Burkitt's lymphoma Blym3. Also there is no obvious or consistent increase in the transcription of the HuBlym-1 gene in Burkitt's lymphoma cell lines of the type that might otherwise have accounted for its transforming activity even in the absence of a mutation. How the HuBlym-1 gene is activated therefore remains a mystery.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Graham, F. V. & van der Eb, A. J. Virology 52, 456–467 (1973).

  2. 2

    Diamond, A., Cooper, G. N., Ritz, J. & Lane, M. A. Nature 305, 112–116 (1983).

  3. 3

    Diamond, A., Devine, J. M. & Cooper, G. M. Science 225, 516–519 (1984).

  4. 4

    Lane, M. A., Sainten, A. & Cooper, G. M. Cell 28, 873–880 (1982).

  5. 5

    Taparowsky, E. et al. Nature 300, 762–765 (1982).

  6. 6

    Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H. & Goeddel, D. V. Nature 302, 33–37 (1983).

  7. 7

    De Feo, D. et al. Proc. natn. Acad. Sci. U.S.A. 78, 3328–3332 (1981).

  8. 8

    Chang, E. H., Furth, M. E., Scolnick, E. H. & Lowry, D. R. Nature 297, 479–483 (1982).

  9. 9

    Goubin, G., Goldman, D. S., Luce, J., Neiman, P. E. & Cooper, G. M. Nature 302, 114–119 (1982).

  10. 10

    Sanger, F., Nicklen, S. & Goulson, A. K. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).

  11. 11

    Maxam, A. M. & Gilbert, W. Meth. Enzym. 65, 499–560 (1980).

  12. 12

    Magrath, I. T. et al. J. natn. Cancer Inst. 64, 465–470 (1980).

  13. 13

    Epstein, M. A. et al. J. natn. Cancer Inst. 37, 547–559 (1966).

  14. 14

    Epstein, M. A. & Achong, B. G. (eds) in The Epstein Barr Virus, 322–337 (Springer, New York, 1979).

  15. 15

    Nichols, W. W. et al. Science 196, 60–63 (1977).

Download references

Author information

Author notes

    • Joan M. Devine

    Present address: Celltech Ltd, 250 Bath Road, Slough, SL1 4EN, Berkshire, UK


  1. Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts, 02115, USA

    • Joan M. Devine


  1. Search for Joan M. Devine in:

About this article

Publication history



Issue Date



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.